HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Flavonoid and lignan intake and pancreatic cancer risk in the European prospective investigation into cancer and nutrition cohort.

Abstract
Despite the potential cancer preventive effects of flavonoids and lignans, their ability to reduce pancreatic cancer risk has not been demonstrated in epidemiological studies. Our aim was to examine the association between dietary intakes of flavonoids and lignans and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. A total of 865 exocrine pancreatic cancer cases occurred after 11.3 years of follow-up of 477,309 cohort members. Dietary flavonoid and lignan intake was estimated through validated dietary questionnaires and the US Department of Agriculture (USDA) and Phenol Explorer databases. Hazard ratios (HR) and 95% confidence intervals (CIs) were calculated using age, sex and center-stratified Cox proportional hazards models, adjusted for energy intake, body mass index (BMI), smoking, alcohol and diabetes status. Our results showed that neither overall dietary intake of flavonoids nor of lignans were associated with pancreatic cancer risk (multivariable-adjusted HR for a doubling of intake = 1.03, 95% CI: 0.95-1.11 and 1.02; 95% CI: 0.89-1.17, respectively). Statistically significant associations were also not observed by flavonoid subclasses. An inverse association between intake of flavanones and pancreatic cancer risk was apparent, without reaching statistical significance, in microscopically confirmed cases (HR for a doubling of intake = 0.96, 95% CI: 0.91-1.00). In conclusion, we did not observe an association between intake of flavonoids, flavonoid subclasses or lignans and pancreatic cancer risk in the EPIC cohort.
AuthorsEsther Molina-Montes, María-José Sánchez, Raul Zamora-Ros, H B As Bueno-de-Mesquita, Petra A Wark, Mireia Obon-Santacana, Tilman Kühn, Verena Katzke, Ruth C Travis, Weimin Ye, Malin Sund, Alessio Naccarati, Amalia Mattiello, Vittorio Krogh, Caterina Martorana, Giovanna Masala, Pilar Amiano, José-María Huerta, Aurelio Barricarte, José-Ramón Quirós, Elisabete Weiderpass, Lene Angell Åsli, Guri Skeie, Ulrika Ericson, Emily Sonestedt, Petra H Peeters, Isabelle Romieu, Augustin Scalbert, Kim Overvad, Matthias Clemens, Heiner Boeing, Antonia Trichopoulou, Eleni Peppa, Pavlos Vidalis, Kay-Tee Khaw, Nick Wareham, Anja Olsen, Anne Tjønneland, Marie-Christine Boutroun-Rualt, Françoise Clavel-Chapelon, Amanda J Cross, Yunxia Lu, Elio Riboli, Eric J Duell
JournalInternational journal of cancer (Int J Cancer) Vol. 139 Issue 7 Pg. 1480-92 (10 01 2016) ISSN: 1097-0215 [Electronic] United States
PMID27184434 (Publication Type: Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't)
Copyright© 2016 The Authors International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC.
Chemical References
  • Flavonoids
  • Lignans
Topics
  • Cohort Studies
  • Diet (statistics & numerical data)
  • Diet Records
  • Europe (epidemiology)
  • Female
  • Flavonoids (administration & dosage)
  • Humans
  • Life Style
  • Lignans (administration & dosage)
  • Male
  • Middle Aged
  • Pancreatic Neoplasms (epidemiology)
  • Proportional Hazards Models
  • Prospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: